Hana Remešová

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Institute of Haematology and Blood Transfusion(Current)

Charles University

University Hospital Brno

Hana Remešová is an author at Institute of Haematology and Blood Transfusion specializing in acute myeloid leukemia therapy, molecular oncology, and medicine.

ORCID

Publications per year

2018–2023

Publications

Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients

Peter Holíček, Iva Truxová, Jana Raková et al. · Cell Death and Disease · 2023 · 26 citations · Full text

Medicine, Immunology, Oncology +17

Relationship between Altered miRNA Expression and DNA Methylation of the DLK1-DIO3 Region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Michaela Dostálová Merkerová, Hana Remešová, Zdeněk Krejčík et al. · Cells · 2018 · 17 citations · Full text

Medicine, Hematology, Molecular Biology +17

Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients

Adam Folta, Martin Čulen, Ivana Ježíšková et al. · British Journal of Haematology · 2019 · 13 citations · Full text

Life Sciences, Genetics, Hematology +15

A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel

Šárka Šestáková, Ela Cerovská, Cyril Šálek et al. · Clinical Epigenetics · 2022 · 12 citations · Full text

Medicine, Genetics, Oncology +15

ABC transporters are predictors of treatment failure in acute myeloid leukaemia

Ela Cerovská, Cyril Šálek, Dávid Kundrát et al. · Biomedicine & Pharmacotherapy · 2023 · 10 citations · Full text

Medicine, Hematology, Oncology +13

1–5 of 5